ScoreWhy is Windlas Biotech Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate 16.10% of over the last 5 years
2
Flat results in Dec 25
- ROCE(HY) Lowest at 8.66%
- PAT(Q) At Rs 15.00 cr has Fallen at -10.9% (vs previous 4Q average)
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 15.03 cr
3
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 7.35% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -16.00% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Windlas Biotech for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Windlas Biotech
-17.2%
-0.37
42.73%
Sensex
7.03%
0.59
11.53%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
16.53%
EBIT Growth (5y)
16.10%
EBIT to Interest (avg)
33.76
Debt to EBITDA (avg)
0.19
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
1.37
Tax Ratio
23.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.37%
ROCE (avg)
21.98%
ROE (avg)
11.97%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
26
Industry P/E
32
Price to Book Value
3.33
EV to EBIT
20.65
EV to EBITDA
14.70
EV to Capital Employed
5.08
EV to Sales
1.86
PEG Ratio
2.93
Dividend Yield
0.68%
ROCE (Latest)
24.60%
ROE (Latest)
12.60%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET SALES(Q)
Highest at Rs 233.10 cr
-8What is not working for the Company
ROCE(HY)
Lowest at 8.66%
PAT(Q)
At Rs 15.00 cr has Fallen at -10.9% (vs previous 4Q average
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 15.03 cr
PBDIT(Q)
Lowest at Rs 0.00 cr.
PBT LESS OI(Q)
Lowest at Rs 0.00 cr.
EPS(Q)
Lowest at Rs 7.12
Loading Valuation Snapshot...
Here's what is working for Windlas Biotech
Net Sales - Quarterly
Highest at Rs 233.10 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Here's what is not working for Windlas Biotech
Profit After Tax (PAT) - Quarterly
At Rs 15.00 cr has Fallen at -10.9% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 16.83 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 0.00 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 0.00 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs 7.12
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 15.03 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
